Brain scans and genes may guide better schizophrenia care

NCT ID NCT06969755

Recruiting now Disease control Sponsor: Northwell Health Source: ClinicalTrials.gov ↗

First seen Apr 30, 2026 · Last updated May 16, 2026 · Updated 3 times

Summary

This study looks at whether genetic markers and brain scans can help doctors choose the most effective medication for people experiencing their first episode of psychosis. Researchers will compare a standard antipsychotic to clozapine in 180 participants aged 18-35. The goal is to improve symptom control while reducing side effects like weight gain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHENIA DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre for Addiction and Mental Health
RECRUITING

Toronto, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••
Feinstein Institute for Medical Research
RECRUITING

Glen Oaks, New York, 11004, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SCHIZOPHENIA DISORDER